Analyst Ratings for Jazz Pharmaceuticals (JAZZ) [Neutrals]

JAZZ Rating Summary

JAZZ Price Target Summary

* Over Last 12-Mos
  |   Expand Research on JAZZ
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $197.94 (+13.4%) * Over Last 12-Mos
Rating Score: 8.9 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/29/2021 Morgan Stanley
» Updated 4/1/2021
David Risinger Downgrade Equalweight
(Overweight)
176.00
(162.00)
163.95
(174.59)
6.49% Details
4/6/2017 Mizuho Securities
» Updated 7/3/2019
Irina Koffler Downgrade Neutral
(Buy)
148.00
(N/A)
143.21
(174.59)
21.91% Details
Like JAZZ Ratings? Also take a look at GWPH, PHM, OYST, EXPR

JAZZ Ratings News